{"id":379467,"date":"2020-11-12T07:33:34","date_gmt":"2020-11-12T12:33:34","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379467"},"modified":"2020-11-12T07:33:34","modified_gmt":"2020-11-12T12:33:34","slug":"cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/","title":{"rendered":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in the <strong>Jefferies Virtual London Healthcare Conference<\/strong> which will take place from November 17 to 19<sup>th<\/sup>, 2020.\u00a0<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:5pt;margin-bottom:5pt;text-align:justify\">Cytovia CEO Dr. Daniel Teper will present on Thursday, November 19<sup>th<\/sup> at 12.55 PM GMT \u2013 7.55 AM EST.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt;text-align:justify\">Company management will be available throughout the conference for one on one virtual meetings from November 17 to November 19, 2020.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt;text-align:justify\">The webcast links will be available on the company website\u00a0and social media pages.\u00a0<\/li>\n<\/ul>\n<p>\n        <strong>ABOUT CYTOVIA THERAPEUTICS<\/strong><br \/>\n        <br \/>Cytovia Therapeutics Inc is an emerging biotechnology company that aims to accelerate patient access to transformational immunotherapies, addressing several of the most challenging unmet medical needs in cancer. Cytovia focuses on Natural Killer (NK) cell biology and is leveraging multiple advanced patented technologies, including an induced pluripotent stem cell (iPSC) platform for CAR (Chimeric Antigen Receptors) NK cell therapy, next-generation precision gene-editing to enhance targeting of NK cells, and NK engager multi-functional antibodies. Our initial product portfolio focuses on both hematological malignancies such as multiple myeloma and solid tumors including hepatocellular carcinoma and glioblastoma. The company partners with the University of California San Francisco (UCSF), the New York Stem Cell Foundation (NYSCF), the Hebrew University of Jerusalem, INSERM and CytoImmune Therapeutics.<\/p>\n<p>Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XQptFPSW9PqbSm58k5ggXEqBDkmCvagdIzYGWyAbxXoe17mMBr05jgsAWOa-auHOlx2052Roq9Kby02lZZzRbmBN4NcIFvQhVMXezgaqNAcLbTwqTjFRlBX6Gen06c3A0GvyxY_yr-BkWeKyQVxSt3-LbZJk4XKFD878iVy-teiCaYks2VrOdq2BXOq0ZxUIpaTycRCUHZ06bWXKt-Es4Guy_qbBzZSfF3FhwuvQ4z4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>www.cytoviatx.com<\/strong><\/a>\u00a0and follow Cytovia Therapeutics on Social Media\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S3xWbOnxZAaKEUlk19swkSAyDkMDravz_NoQd5YnDiZaq3zAUuAgRBNDClWXMOHUm5D3fxvx6WucsvxRQdYjtgk3vS4LojUwKcctlY7H_s_Ry4ylcN4CPRvSSCkb1CA6xMfupTtmvqLqSKnEFHYTl1S3p4Edm16U9KhLe1PswoNxOFGOuIqO3hNawE84SrL_Od9PjdMv9mtEHP3abbM5Q8uwjQIXalIOWXas5v4V6ntyorHIE-ho98txAtESOjVi\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>Facebook<\/strong><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZMYCKCi5fwReGPONsl-ZZw1l2y-oG8rGJ8smjEyuqb-zem8eGp6R60fxY_F1Z6HBJFALOWlQq1y9hsnQR27G7eJL7v5--uxqMdl9kT-NMnrrNfjaiaZuVe0kRjqI061_LOPeWfshBVj_JVYZCluzcWs7Ku6xuc2wSWe_je4XrVsCO95_i8NweHmdDQApG0Dg88H4x3l2EaIoEPAVszSlu74JWd5tZEPOjWI-kfUg8Hzar4L6DhHotcxQk6viyJXm121Nf6UjRbyC7Oz5DJn9JA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>LinkedIn<\/strong><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OsNL2kvWRCNBhlgvV2qH4p0ACn51-4YBm_J19ET5ANn6Z0lXgOhTY3YTkIBK9PaIGZhjp_iBgxbpze4XXKFRiSdLJEyb0S3_0o6b8AdxPVCtRpeW03KWWFyZbf2z2vYkcEghqr8qz2E1Ml01BQNXj9mngknd-ui8bNGdib-Od5dlK4CF8adcgAIk1njYdMOAg3qNWcuPebOb_X5qcj3bwA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>Twitter<\/strong><\/a>.<\/p>\n<p>\n        <strong>For more information please contact:<\/strong><br \/>\n        <br \/>Cytovia Therapeutics, Inc<br \/><strong>Sophie <\/strong><strong>Badr\u00e9<\/strong>, Vice President, Corporate Affairs<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lG7XNO14JjXve-EaxOMRS_VDnTrzvU51lk1kvGag0PLhFJmBv-dRTToc6oIReZSIjdPHLOMxMZhrkxNwddDJq2Ar9GXkQ0xqoGfZzUMNcacTtu433bqlrGwq8jqk8aP-\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>sophie.badre@cytoviatx.com<\/strong><\/a>\u00a0<br \/>Cell: 1 (929) 317 1565\u00a0<\/p>\n<p>\n        <strong>Anna Baran<\/strong><br \/>\n        <strong>-Djokovic, <\/strong>VP Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7im8oI2tTM2CCoS1ImdoAa_AxUEozUlvATg1bVR75MIIrs59bz58_jk71K29W4KDekoUFfVMmDJoB8SFvyXufdAnq_eLF84Dmz_jMz0aIf0=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">anna@cytoviatx.com<\/a><br \/>VP Investor Relations<br \/>Cell: +44 7521083006\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in the Jefferies Virtual London Healthcare Conference which will take place from November 17 to 19th, 2020.\u00a0 Cytovia CEO Dr. Daniel Teper will present on Thursday, November 19th at 12.55 PM GMT \u2013 7.55 AM EST. Company management will be available throughout the conference for one on one virtual meetings from November 17 to November 19, 2020. The webcast links will be available on the company website\u00a0and social media pages.\u00a0 ABOUT CYTOVIA THERAPEUTICS Cytovia Therapeutics Inc is an emerging biotechnology company that aims to accelerate patient access to transformational immunotherapies, addressing several of the most &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379467","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in the Jefferies Virtual London Healthcare Conference which will take place from November 17 to 19th, 2020.\u00a0 Cytovia CEO Dr. Daniel Teper will present on Thursday, November 19th at 12.55 PM GMT \u2013 7.55 AM EST. Company management will be available throughout the conference for one on one virtual meetings from November 17 to November 19, 2020. The webcast links will be available on the company website\u00a0and social media pages.\u00a0 ABOUT CYTOVIA THERAPEUTICS Cytovia Therapeutics Inc is an emerging biotechnology company that aims to accelerate patient access to transformational immunotherapies, addressing several of the most &hellip; Continue reading &quot;Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T12:33:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference\",\"datePublished\":\"2020-11-12T12:33:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/\",\"name\":\"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\",\"datePublished\":\"2020-11-12T12:33:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk","og_description":"NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today announced that it will participate in the Jefferies Virtual London Healthcare Conference which will take place from November 17 to 19th, 2020.\u00a0 Cytovia CEO Dr. Daniel Teper will present on Thursday, November 19th at 12.55 PM GMT \u2013 7.55 AM EST. Company management will be available throughout the conference for one on one virtual meetings from November 17 to November 19, 2020. The webcast links will be available on the company website\u00a0and social media pages.\u00a0 ABOUT CYTOVIA THERAPEUTICS Cytovia Therapeutics Inc is an emerging biotechnology company that aims to accelerate patient access to transformational immunotherapies, addressing several of the most &hellip; Continue reading \"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T12:33:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference","datePublished":"2020-11-12T12:33:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/","name":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=","datePublished":"2020-11-12T12:33:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NDk1MCMzODIzNTc3IzIxOTAwMDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytovia-therapeutics-to-present-at-jefferies-virtual-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379467"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379467\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}